{"pmid":32292590,"pmcid":"PMC7152908","title":"All about COVID-19 in brief.","text":["All about COVID-19 in brief.","New Microbes New Infect","NaserGhandi, Alvand","Allameh, Seyed Farshad","Saffarpour, Reyhaneh","32292590"],"journal":"New Microbes New Infect","authors":["NaserGhandi, Alvand","Allameh, Seyed Farshad","Saffarpour, Reyhaneh"],"date":"2020-04-16T11:00:00Z","year":2020,"_id":"32292590","week":"202016|Apr 13 - Apr 19","doi":"10.1016/j.nmni.2020.100678","source":"PubMed","topics":["Transmission","Diagnosis","Treatment"],"weight":1,"_version_":1664266295674142720,"score":8.233237,"similar":[{"pmid":32109444,"pmcid":"PMC7102581","title":"Coronavirus 2019-nCoV: A brief perspective from the front line.","text":["Coronavirus 2019-nCoV: A brief perspective from the front line.","A novel coronavirus, designated as 2019-nCoV, hit the central Chinese city of Wuhan in late December 2019, and subsequently spread rapidly to all provinces of China and multiple countries. As of 0:00 am February 9, 2020, a total of 37,287 cases have been confirmed infection of 2019-nCoV in China mainland, and 302 cases have also been cumulatively reported from 24 countries. According to the latest data, a total of 813 deaths occurred in China mainland, with the mortality reaching approximately 2.2%. At present, there is no vaccine or specific drugs for the human coronavirus. Therefore, it is critical to understand the nature of the virus and its clinical characteristics, in order to respond to the 2019-nCoV outbreak. Thus, the present study briefly but comprehensively summarizes the not much but timely reports on the 2019-nCoV.","J Infect","Han, Qingmei","Lin, Qingqing","Jin, Shenhe","You, Liangshun","32109444"],"abstract":["A novel coronavirus, designated as 2019-nCoV, hit the central Chinese city of Wuhan in late December 2019, and subsequently spread rapidly to all provinces of China and multiple countries. As of 0:00 am February 9, 2020, a total of 37,287 cases have been confirmed infection of 2019-nCoV in China mainland, and 302 cases have also been cumulatively reported from 24 countries. According to the latest data, a total of 813 deaths occurred in China mainland, with the mortality reaching approximately 2.2%. At present, there is no vaccine or specific drugs for the human coronavirus. Therefore, it is critical to understand the nature of the virus and its clinical characteristics, in order to respond to the 2019-nCoV outbreak. Thus, the present study briefly but comprehensively summarizes the not much but timely reports on the 2019-nCoV."],"journal":"J Infect","authors":["Han, Qingmei","Lin, Qingqing","Jin, Shenhe","You, Liangshun"],"date":"2020-02-29T11:00:00Z","year":2020,"_id":"32109444","week":"20209|Feb 24 - Mar 01","doi":"10.1016/j.jinf.2020.02.010","keywords":["*2019-nCoV","*Epidemiology","*Genomic","*Therapeutic"],"source":"PubMed","locations":["Wuhan","Chinese","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Mechanism","Diagnosis","Treatment"],"weight":1,"_version_":1663352134392872960,"score":55.256443},{"pmid":32302257,"title":"COVID-19 Transmission in Dental Practice: Brief Review of Preventive Measures in Italy.","text":["COVID-19 Transmission in Dental Practice: Brief Review of Preventive Measures in Italy.","The outbreak and diffusion of SARS-CoV-2, responsible for the coronavirus disease (COVID-19), has caused an emergency in the health system worldwide. After a first development in Wuhan, China, the virus spread in other countries, with Italy registering the second highest number of cases in Europe on the 7th of April 2020 (135,586 in total). The World Health Organization declared the pandemic diffusion of COVID-19, and restrictive measures to limit contagion have been taken in several countries. The virus has a predominantly respiratory transmission through aerosol and droplets. The importance of infection control is therefore crucial in limiting the effects of virus diffusion. We aim to discuss the risks related to dental practice and current recommendations for dental practitioners. A literature search was performed to retrieve articles on the management of COVID-19 diffusion in dental practice. The documented clinical experience, the measures of professional prevention, and the actual Italian situation were reported and described. Four articles were retrieved from the literature search. Among the eligible articles, 3 reported measures to contrast COVID-19 diffusion. The infection management protocols suggested were reviewed. Finally, recommendations based on the Italian experience in terms of patient triage, patients' entrance into the practice, dental treatment, and after-treatment management are reported and discussed. COVID-19 is a major emergency worldwide, which should not be underestimated. Due to the rapidly evolving situation, further assessment of the implications of COVID-19 outbreak in dental practice is needed.","J Dent Res","Izzetti, R","Nisi, M","Gabriele, M","Graziani, F","32302257"],"abstract":["The outbreak and diffusion of SARS-CoV-2, responsible for the coronavirus disease (COVID-19), has caused an emergency in the health system worldwide. After a first development in Wuhan, China, the virus spread in other countries, with Italy registering the second highest number of cases in Europe on the 7th of April 2020 (135,586 in total). The World Health Organization declared the pandemic diffusion of COVID-19, and restrictive measures to limit contagion have been taken in several countries. The virus has a predominantly respiratory transmission through aerosol and droplets. The importance of infection control is therefore crucial in limiting the effects of virus diffusion. We aim to discuss the risks related to dental practice and current recommendations for dental practitioners. A literature search was performed to retrieve articles on the management of COVID-19 diffusion in dental practice. The documented clinical experience, the measures of professional prevention, and the actual Italian situation were reported and described. Four articles were retrieved from the literature search. Among the eligible articles, 3 reported measures to contrast COVID-19 diffusion. The infection management protocols suggested were reviewed. Finally, recommendations based on the Italian experience in terms of patient triage, patients' entrance into the practice, dental treatment, and after-treatment management are reported and discussed. COVID-19 is a major emergency worldwide, which should not be underestimated. Due to the rapidly evolving situation, further assessment of the implications of COVID-19 outbreak in dental practice is needed."],"journal":"J Dent Res","authors":["Izzetti, R","Nisi, M","Gabriele, M","Graziani, F"],"date":"2020-04-18T11:00:00Z","year":2020,"_id":"32302257","week":"202016|Apr 13 - Apr 19","doi":"10.1177/0022034520920580","keywords":["dental education","dental public health","infection control","practice management","prevention","virology"],"source":"PubMed","topics":["Transmission","Prevention"],"weight":1,"locations":["Wuhan","China","Italy","Italian","Italian","Italy"],"countries":["China","Italy"],"countries_codes":["CHN|China","ITA|Italy"],"_version_":1664357978535362560,"score":53.067726},{"pmid":32250388,"title":"The COVID-19 Pandemic in the US: A Clinical Update.","text":["The COVID-19 Pandemic in the US: A Clinical Update.","JAMA","Omer, Saad B","Malani, Preeti","Del Rio, Carlos","32250388"],"journal":"JAMA","authors":["Omer, Saad B","Malani, Preeti","Del Rio, Carlos"],"date":"2020-04-07T11:00:00Z","year":2020,"_id":"32250388","week":"202015|Apr 06 - Apr 12","doi":"10.1001/jama.2020.5788","source":"PubMed","locations":["US"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Diagnosis","Transmission","Prevention","Treatment"],"weight":1,"_version_":1663352136207958017,"score":48.128754},{"pmid":32255507,"title":"COVID-19 And Older Adults: What We Know.","text":["COVID-19 And Older Adults: What We Know.","SARS-CoV-2, a novel virus that causes COVID-19 infection, has recently emerged and caused a deadly pandemic. Studies have shown that this virus causes worse outcomes and a higher mortality rate in older adults and those with comorbidities such as hypertension, cardiovascular disease, diabetes, chronic respiratory disease, and chronic kidney disease. A significant percentage of older American adults have these diseases, putting them at a higher risk of infection. Additionally, many adults with hypertension, diabetes, and chronic kidney disease are placed on angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs). Studies have shown that these medications upregulate the ACE-2 receptor, the very receptor which the SARS-CoV-2 virus uses to enter host cells, which puts older adults at a further increased risk of infection. In this review, we discuss the transmission, symptomatology, mortality, and possible treatments for this infection, as they relate to older adults. This article is protected by copyright. All rights reserved.","J Am Geriatr Soc","Shahid, Zainab","Kalayanamitra, Ricci","McClafferty, Brendan","Kepko, Douglas","Ramgobin, Devyani","Patel, Ravi","Aggarwal, Chander Shekher","Vunnam, Rama Rao","Sahu, Nitasa","Bhatt, Dhirisha","Jones, Kirk","Golamari, Reshma","Jain, Rohit","32255507"],"abstract":["SARS-CoV-2, a novel virus that causes COVID-19 infection, has recently emerged and caused a deadly pandemic. Studies have shown that this virus causes worse outcomes and a higher mortality rate in older adults and those with comorbidities such as hypertension, cardiovascular disease, diabetes, chronic respiratory disease, and chronic kidney disease. A significant percentage of older American adults have these diseases, putting them at a higher risk of infection. Additionally, many adults with hypertension, diabetes, and chronic kidney disease are placed on angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs). Studies have shown that these medications upregulate the ACE-2 receptor, the very receptor which the SARS-CoV-2 virus uses to enter host cells, which puts older adults at a further increased risk of infection. In this review, we discuss the transmission, symptomatology, mortality, and possible treatments for this infection, as they relate to older adults. This article is protected by copyright. All rights reserved."],"journal":"J Am Geriatr Soc","authors":["Shahid, Zainab","Kalayanamitra, Ricci","McClafferty, Brendan","Kepko, Douglas","Ramgobin, Devyani","Patel, Ravi","Aggarwal, Chander Shekher","Vunnam, Rama Rao","Sahu, Nitasa","Bhatt, Dhirisha","Jones, Kirk","Golamari, Reshma","Jain, Rohit"],"date":"2020-04-08T11:00:00Z","year":2020,"_id":"32255507","week":"202015|Apr 06 - Apr 12","doi":"10.1111/jgs.16472","keywords":["COVID-19","Coronavirus","Mortality","Older Adults","SARS-CoV-2"],"source":"PubMed","locations":["American"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Transmission","Diagnosis","Treatment"],"weight":1,"_version_":1663450393559957504,"score":48.128754},{"pmid":32290887,"title":"COVID-19: What Paramedics Need to Know!","text":["COVID-19: What Paramedics Need to Know!","CJEM","Buick, Jason E","Cheskes, Sheldon","Feldman, Michael","Verbeek, P Richard","Hillier, Morgan","Leong, Yuen Chin","Drennan, Ian R","32290887"],"journal":"CJEM","authors":["Buick, Jason E","Cheskes, Sheldon","Feldman, Michael","Verbeek, P Richard","Hillier, Morgan","Leong, Yuen Chin","Drennan, Ian R"],"date":"2020-04-16T11:00:00Z","year":2020,"_id":"32290887","week":"202016|Apr 13 - Apr 19","doi":"10.1017/cem.2020.367","source":"PubMed","topics":["Transmission","Diagnosis","Prevention","Treatment"],"weight":1,"_version_":1664266295608082432,"score":48.128754}]}